Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease
NCT04806737
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Celiac Disease
Interventions
DRUG:
Teriflunomide Oral Tablet
Sponsor
Oslo University Hospital